Categories: News

Development of second campus of Chittaranjan National Cancer Institute at Rajarhat, Kolkata


New Delhi February 7, 2014:- The Cabinet Committee on Economic Affairs has approved the development of the first phase of the second campus of the Chittaranjan National Cancer Institute (CNCI), Kolkata at an estimated total cost of Rs. 534 crore of which the Central share will be Rs. 400 crore. 


This will be a 460-bedded hospital with modern state-of-the-art facilities for comprehensive care and diagnosis of cancer. The new campus, located at Rajarhat near the airport is to be completed in 30 months. The facilities will include radiation oncology, surgical oncology, medical oncology, cancer diagnostics, preventive oncology, palliative care etc. 

The CNCI is a National Cancer Institute which caters to West Bengal and the States of the East and the North-East. The existing campus has only 200 beds with constraints of an old building and limited land resulting in a very high patient load. The new campus has been envisaged to meet the objectives of affordable and accessible tertiary level care for treating cancer. The new facilities will also address the current regional imbalance in the availability of tertiary care cancer facilities. Development of human resources in various fields of cancer treatment will also receive a much needed impetus. 

Background:

Cancer is emerging as a major public health concern in India. 11 lakh new cases are diagnosed every year and the mortality rate is 5.5 lakh per year. Cancer treatment facilities in India are lagging behind when compared to World Health Organisation (WHO) standards which require one radiotherapy machine per million population. India at present has 0.41 machines per million population. The setting up of the second campus of the cancer institute at Rajarhat will be a new chapter in the initiative against cancer. 

This approval comes in addition to the National Cancer Institute approved at Jhajjar and the setting up of 20 State Cancer Institutes and 50 Tertiary Care Cancer Centres in different parts of the country. 

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago